Mark Erlander Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mark Erlander.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark Erlander. Mark Erlander is an Chief Executive Officer in Cardiff Oncology, Inc. ($XNOM.OB) and a Chief Scientific Officer in Trovagene, Inc. ($XNOM.OB).
Address: C/O TROVAGENE, INC., 11055 FLINTKOTE AVENUE, SUITE A SAN DIEGO 92121 CA
Companies in which Mark Erlander is an Insider
Cardiff Oncology, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Mark Erlander: Chief Executive Officer, Chief Scientific Officer
Holdings: 14,481 shares
Latest Transaction: Mar 23 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Mark Erlander
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 23 2021 | XNOM.OB | Cardiff Oncology, ... | Erlander Mark | Chief Executive Off ... | Buy | P | 10.34 | 965 | 9,980 | 14,481 | 13.5 K to 14.5 K (+7.14 %) |
| Jan 05 2021 | XNOM.OB | Cardiff Oncology, ... | Erlander Mark | Chief Executive Off ... | Option Exercise | M | 0.00 | 260 | 0 | 0 | |
| Jan 05 2021 | XNOM.OB | Cardiff Oncology, ... | Erlander Mark | Chief Executive Off ... | Payment of Exercise | F | 0.00 | 113 | 0 | 13,516 | 13.6 K to 13.5 K (-0.83 %) |
| Jan 05 2021 | XNOM.OB | Cardiff Oncology, ... | Erlander Mark | Chief Executive Off ... | Buy | M | 0.00 | 260 | 0 | 13,629 | 13.4 K to 13.6 K (+1.94 %) |
| May 18 2020 | XNOM.OB | Cardiff Oncology, ... | Erlander Mark | Chief Executive Off ... | Buy | P | 1.43 | 6,993 | 10,000 | 13,369 | 6.4 K to 13.4 K (+109.68 %) |
| Oct 03 2019 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Option Exercise | M | 0.00 | 1,250 | 0 | 1,771 | |
| Oct 03 2019 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Payment of Exercise | F | 0.00 | 466 | 0 | 5,533 | 6 K to 5.5 K (-7.77 %) |